Sensus Healthcare, Inc.
SRTS
Rank in Stocks
#22545
Sensus Healthcare, Inc. operates as a medical technology enterprise,... Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy. This device presents a non-surgical alternative for patients dealing with non-melanoma skin cancers, including basal cell and squamous cell carcinomas, alongside other dermatological issues like keloids. Another key offering is the SRT-100 Vision, which incorporates a specialized SRT treatment planning application. This application seamlessly integrates an embedded high-frequency ultrasound imaging module, tools for volumetric tumor analysis, beam margin delineation, and dosimetry parameter configuration. In addition, Sensus Healthcare provides the SRT-100 Plus, the Sentinel service program to ensure system protection for its clients, and options for in-office laser rentals. They also supply various consumable items, such as replacement lead shielding, disposable radiation safety gear like aprons and eye shields, ultrasound probe film, and single-use applicator tips designed to treat lesions of different sizes and on various body areas. Founded in 2010, Sensus Healthcare, Inc. maintains its corporate headquarters in Boca Raton, Florida.
Share Price
$3.18
Last synced: 2026-11-09
Market Cap
$52.35M
Change (1 day)
11.19%
Change (1 year)
-24.47%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Sensus Healthcare, Inc. (SRTS)
Category
Healthcare
EPS for Sensus Healthcare, Inc. (SRTS)
EPS as of June 2026 TTM: $-0.94
According to Sensus Healthcare, Inc.'s latest financial reports, its current EPS (TTM) is $-0.94. At the end of 2025 the company had an EPS of $-0.47, a decrease compared to its 2024 EPS of $0.41.
EPS history for Sensus Healthcare, Inc. from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.94 | 100.00% |
| 2025 | $-0.47 | -214.63% |
| 2024 | $0.41 | 1,275.84% |
| 2023 | $0.03 | -97.97% |
| 2022 | $1.47 | 488.00% |
| 2021 | $0.25 | -159.52% |
| 2020 | $-0.42 | 490.72% |
| 2019 | $-0.07 | -49.21% |
| 2018 | $-0.14 | -50.00% |
| 2017 | $-0.28 | 872.22% |
| 2016 | $-0.03 | 30.91% |
| 2015 | $-0.02 | -94.05% |
| 2014 | $-0.37 | 802.44% |
| 2013 | $-0.04 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -387.23% |
US
|
|
| $4.09 | -535.11% |
IE
|
|
| $9.45 | -1,105.32% |
US
|
|
| $2.37 | -352.13% |
US
|
|
| $1.77 | -288.30% |
US
|
Questions about Sensus Healthcare, Inc.'s earnings per share (EPS)
What is Sensus Healthcare, Inc.'s earnings per share (EPS)?
Sensus Healthcare, Inc.'s earnings per share (EPS) over the last twelve months is $-0.94, as of Jun 2026.
What was Sensus Healthcare, Inc.'s earnings per share (EPS) in 2025?
In 2025, Sensus Healthcare, Inc.'s earnings per share (EPS) was $-0.47, compared with $0.41 in 2024.
How has Sensus Healthcare, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Sensus Healthcare, Inc.'s earnings per share (EPS) was highest in 2022 ($1.47) and lowest in 2025 ($-0.47).
How does Sensus Healthcare, Inc.'s earnings per share (EPS) compare with similar companies?
Sensus Healthcare, Inc.'s earnings per share (EPS) ($-0.94) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.